Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Resoloy Initial Safety Evaluation

NCT07648017 is registered in ClinicalTrials.gov with MeKo Manufacturing e.K. as lead sponsor.

NCT NCT07648017
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07648017 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Resoloy Initial Safety Evaluation
Lead sponsor
MeKo Manufacturing e.K.
Phase
Not applicable
Overall status
Active, not recruiting
Start date
August 23, 2025
Completion date
December 1, 2027
Enrollment
10 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

clti defined as rutherford category 4 or 5, paod (peripheral arterial obstructive disease)